PropertyValue
nif:beginIndex
  • 0 (xsd:integer)
nif:broaderContext
nif:endIndex
  • 150 (xsd:integer)
nif:isString
  • Vicriviroc is another CCR5 inhibitor by Schering Plough currently in phase III clinical trials that binds a similar transmembrane pocket as maraviroc.
rdf:type